Posted in J&J, Johnson and Johnson, Oncology, Pharma, Pharma News, Pharmaceutical, Roche, tagged asco, HGH, Tamiflu on May 24, 2010|
We’re in the pre-ASCO oncology news build-up phase. Here’s a brief preview. And even more here.
Does HGH really help athletes? Interesting article – the last paragraph is the kicker.
Whistleblowers (J&J) get a payday. And, allegations about illegal sales practices by Roche with Tamiflu.
eLearning. We know that space inside and out, and we have great partners to recommend. Contact us (stevew at impactiviti dot com, or phone at 973-947-7429) for recommendations.
Karl Schmieder of MessagingLab interviews me about Impactiviti. Plus – the timing is never really “right,” is it? 29 and Counting.
JUST FOR FUN
If this doesn’t make you want to visit South America some day, nothing will!
AND, a pharma spoof – So, What’s your Problem with Gram-Negative Bacteria?
Subscribe to the Impactiviti blog via e-mail (which will bring you Impactiviti Daily – a brief of the day’s top pharma news)
Visit the Impactiviti Job Board
Sign up for the Impactiviti Connection twice-monthly e-newsletter (see sample)
Read Full Post »
Posted in Medicine, Pfizer, Pharma, Pharma News, Pharmaceutical, Roche, Sanofi-Aventis, Top News, Training Needs, tagged depression, Tamiflu on December 10, 2009|
So…is Roche‘s Tamiflu really that effective? – The effectiveness of Roche Holding AG’s Tamiflu in treating flu complications in healthy adults can’t be determined because the Swiss drugmaker wouldn’t supply data from eight studies, an independent research group said…more
The pharma layoff toll in 2009. Ugly.
Pfizer to move into biosimilars? Not a bad long-term strategy, actually: focused diversification – Pfizer Inc., which became the biggest drugmaker selling widely prescribed pills such as the Lipitor heart medicine, is preparing to enter the business of making cheaper copies of pricey, injectable drugs from biotechnology…more
Do those anti-depressants work? Maybe at a deeper level than previously thought – Antidepressant medications taken by roughly 7% of American adults cause profound personality changes in many patients with depression, far beyond simply lifting the veil of sadness, a study has found. Researchers saw strong drops in neuroticism and increases in extroversion in patients taking antidepressants, two of five traits thought to define personality and shape a person’s day-to-day thoughts and behavior. The findings are striking, researchers said, because psychologists have long thought that such fundamental traits are moorings of an adult’s personality that shift very little over a lifetime…more
Train-the-Trainer. Looking for a well-structured but customizable program for training your new sales trainers? The Impactiviti network can help you. Contact us (stevew at impactiviti dot com, or phone at 973-947-7429) for recommendations.
JUST FOR FUN
Read Full Post »